...
首页> 外文期刊>Transfusion medicine >A life-threatening episode of treatment-resistant haemolysis in a pregnant patient with dyserythropoietic anaemia (CDA) type I
【24h】

A life-threatening episode of treatment-resistant haemolysis in a pregnant patient with dyserythropoietic anaemia (CDA) type I

机译:I型失血性贫血(CDA)孕妇的致命性治疗难治性溶血发作

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Congenital dyserythropoietic anaemia type I (CDA type I) is a rare autosomal recessive disorder, caused by a mutation in CDAN1 gene on chromosome 15. It is associated with mild anaemia, iron overloading, gallstones and splenomegaly (Heimpel et ah, 2006). Information on the management of CDA in pregnancy is scarce, but patients mostly become transiently transfusion-dependent. Prematurity, small birth weight and early neonatal jaundice occur frequently (Shalev etal., 2008). Here, we present a pregnant female with CDA type I and life-threatening treatment refractory haemolysis, which started after red blood cell transfusion and finally responded to splenectomy.
机译:I型先天性非人类造血障碍(CDA型)是一种罕见的常染色体隐性遗传疾病,由15号染色体上的CDAN1基因突变引起。它与轻度贫血,铁超负荷,胆结石和脾肿大相关(Heimpel等,2006)。关于妊娠CDA管理的信息很少,但患者大多会暂时依赖输血。早产,低出生体重和新生儿早期黄疸经常发生(Shalev等,2008)。在这里,我们介绍了一位患有CDA I型和威胁生命的治疗难治性溶血的孕妇,其在输注红细胞后开始,最后对脾切除术产生了反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号